首页> 外文OA文献 >Inhibition of human coagulation factor VIII by monoclonal antibodies. Mapping of functional epitopes with the use of recombinant factor VIII fragments.
【2h】

Inhibition of human coagulation factor VIII by monoclonal antibodies. Mapping of functional epitopes with the use of recombinant factor VIII fragments.

机译:单克隆抗体对人凝血因子的抑制作用。使用重组因子VIII片段定位功能性表位。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The epitopes of four monoclonal antibodies against coagulation Factor VIII were mapped with the use of recombinant DNA techniques. Full-length Factor VIII cDNA and parts thereof were inserted into the vector pSP64, permitting transcription in vitro with the use of a promoter specific for SP6 RNA polymerase. Factor VIII DNA inserts were truncated from their 3'-ends by selective restriction-enzyme digestion and used as templates for 'run-off' mRNA synthesis. Translation in vitro with rabbit reticulocyte lysate provided defined radiolabelled Factor VIII fragments for immunoprecipitation studies. Two antibodies are shown to be directed against epitopes on the 90 kDa chain of Factor VIII, between residues 712 and 741. The 80 kDa chain appeared to contain the epitopes of the other two antibodies, within the sequences 1649-1778 and 1779-1840 respectively. The effect of antibody binding to these sequences was evaluated at two distinct levels within the coagulation cascade. Both Factor VIII procoagulant activity and Factor VIII cofactor function in Factor Xa generation were neutralized upon binding to the region 1779-1840. The antibodies recognizing the region 713-740 or 1649-1778, though interfering with Factor VIII procoagulant activity, did not inhibit in Factor Xa generation. These findings demonstrate that antibodies that virtually inhibit Factor VIII in coagulation in vitro are not necessarily directed against epitopes involved in Factor VIII cofactor function. Inhibition of procoagulant activity rather than of cofactor function itself may be explained by interference in proteolytic activation of Factor VIII. This hypothesis is in agreement with the localization of the epitopes in the proximity of thrombin-cleavage or Factor Xa-cleavage sites.
机译:使用重组DNA技术对四种抗凝血因子的单克隆抗体的表位进行了定位。将全长因子VIII cDNA及其部分插入到载体pSP64中,从而允许使用对SP6 RNA聚合酶具有特异性的启动子进行体外转录。通过选择性限制性内切酶消化,将因子VIII DNA插入物从其3'末端截短,并用作“尾随” mRNA合成的模板。兔网织红细胞裂解物的体外翻译为免疫沉淀研究提供了确定的放射性标记的VIII因子片段。已显示两种抗体针对因子VIII的90 kDa链上位于残基712和741之间的表位。80 kDa链似乎分别包含其他两种抗体的表位,分别在序列1649-1778和1779-1840中。在凝血级联反应的两个不同水平上评估了抗体与这些序列结合的效果。结合区域1779-1840后,因子Xa生成中的因子VIII促凝活性和因子VIII辅助因子功能均被中和。识别区域713-740或1649-1778的抗体,尽管干扰因子VIII促凝活性,但不抑制因子Xa的产生。这些发现表明,在体外凝血中实际上抑制因子VIII的抗体不一定针对涉及因子VIII辅因子功能的表位。抑制促凝血活性而不是抑制辅因子功能本身可以通过干扰因子VIII的蛋白水解激活来解释。该假设与在凝血酶切割或因子Xa切割位点附近的表位的定位一致。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号